dCas9-sgLINC00261 system for inhibiting pancreatic cancer progression, construction method and application
A technology of dcas9-sglinc00261 and construction method, which is applied in the field of tumor molecular biology to enrich the regulatory mechanism and enhance the effect of inhibition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0027] The construction method of dCas9-sgLINC00261 system comprises the following steps:
[0028] S1: Construct a stable CRISPR-dCas9 pancreatic cancer cell line using lentivirus; the sequence of the actual components of the lentivirus is EF1a-Dcas9-Tet1CD-CMV-EGFP, and the relevant steps are as follows:
[0029] A. Cell Plating
[0030] 90% confluent pancreatic cancer cells (CFPAC-1 and PANC-1 cell lines) were digested with trypsin to make a cell suspension, and the cell suspension (the number of cells was about 5×10 4 / mL) inoculated in 6-well, at 37°C, 5% CO 2 cultivated in an incubator;
[0031] B. Lentiviral Infection of Target Cells
[0032] After the cells in step A were cultured for 24 hours, when the degree of cell fusion reached about 30%, according to the MOI value of the cells (i.e. the multiplicity of infection value, the MOI values of different cell lines of pancreatic cancer were different, the MOI value of PANC-1 was 10 , BXPC-3 and CFPAC-1 MOI values ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com